An interventional study of Intraocular lens in Cataract Senile and Pseudophakia, sponsored by Brighton and Sussex University Hospitals NHS Trust. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-11-25.
Sponsored by Brighton and Sussex University Hospitals NHS Trust · Not applicable, Interventional, and Treatment
Cataract surgery involves replacing milky lens with a plastic intraocular lens. This plastic lens can be either monofocal (fixates for distance or near without glasses), extended depth of focus (EDOF)(fixates for intermediate and distance vision only without glasses) or multifocal lenses (fixates for distance, intermediate and near vision without glasses). However, EDOF and multifocal lenses are known to produce glare and halos. Tecnis Eyhance (Johnson \& Johnson, USA) is a monofocal IOL which give added intermediate vision without employing EDOF or multifocal technology and hence induces no glare and halos. Whereas monofocal IOLs such as RayOne do not give intermediate vision. The objective is to assess visual and optical performance of Tecnis Eyhance versus Rayner RayOne in a prospective, randomized, comparative bilateral study. The proposed study will be the first study comparing the new technology monofocal Eyhance with conventional RayOne Rayner lens to assess the added benefits of Eyhance technology at multiple visits until 3 months after the surgery. Patients attending the clinics with cataracts will be invited to participate in this randomised study. They will be randomised to receive either Eyhance or RayOne in both eyes through surgeries performed not more than 2 weeks apart. The patients will be followed up at 1 and 3 months in the research clinic to assess the uniocular and binocular vision, spectacle prescription, a simple non-invasive scan to look at any distortions in the optics of the eye (wavefront aberrometry) and questionnaire for assessing subjective outcomes, glare and halos.
Study design:
Prospective, randomised, comparative study assessing visual and optical outcomes after bilateral implantation of the new Johnson \& Johnson Tecnis Eyhance versus monofocal Rayner RayOne in patients undergoing routine cataract surgery.
Methodology:
Suitable patients with cataracts in both eyes will be identified from cataract assessment clinics. They will be invited to participate in the study by the research nurse and handed over the patient information sheet and a consent form. The PI will consent the patient for the participation. If they agree to participate, they will be give the dates for their surgeries on the same day. The patients can choose to have both eyes done on the same day or two eyes within 2 weeks based on the patients convenience. If they chose to participate in the study, then the patient will have additional tests performed on the day of their cataract assessment clinic. This will take an additional 40 minutes.
On the day of the surgery, the patients will be randomised using a computer generated randomisation to receive either Tecnis Eyhance or the Rayner RayOne lens. They will have the same lens in both eyes. The patients will be invited for a research follow up visit at 1 (between 30-37 days after 2nd eye surgery) and 3 months (90-100 days after 2nd eye surgery) were simple research tests will performed including vision assessment and a scan.
At preoperative visit and 3 months the patients will be asked to fill in a questionnaire.
54 studies on the registry are indexed under Pseudophakia; 8 are open to participants now.
This study's planned enrollment of 50 is above the median of 45 across 25 interventional studies indexed under Pseudophakia.
Browse Pseudophakia studies →Brighton and Sussex University Hospitals NHS Trust is the lead sponsor of 22 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients undergoing routine cataract surgery with:
Exclusion Criteria:
Tecnis Eyhance hydrophobic IOL is a monofocal IOL with added advantage of slightly better unaided intermediate vision at 60 cms.
Device: Intraocular lens
Rayner Rayone is a monofocal hydrophilic IOL which is not intended to give better unaided or near vision.
Device: Intraocular lens
Tecnis Eyhance is a monofocal IOL which give added intermediate vision without employing EDOF or multifocal technology and hence induces no glare and halos. Whereas monofocal IOLs such as RayOne do not give intermediate vision.
Unaided distance visual acuity (UCDVA) (Uniocular and binocular)
Uniocular and binocular uncorrected distance vision will be measured at the follow ups.
Time frame: 3 months postoperatively
Unaided intermediate visual acuity (UIVA) (uniocular and binocular)
Uniocular and binocular unaided intermediate vision will be measured at the follow ups
Time frame: 3 months postoperatively
Best corrected distance LogMAR visual acuity (CDVA) (uniocular and binocular)
Uniocular and binocular best spectacle corrected distance vision will be measured at the follow ups
Time frame: 1 and 3 months postoperatively
Manifest refraction (Diopters)
Sphere, cylinder and axis of the manifest refraction will be recorded at follow ups
Time frame: 1 and 3 months postoperatively
Defocus Curves (Diopters)
Defocus curves will be plotted by adding + and - lenses to the manifest refraction
Time frame: 1 and 3 months postoperatively
Distance correct intermediate LogMAR visual acuity (DCIVA) at 60 cm
Uniocular and binocular best spectacle corrected intermediate vision will be recorded at follow ups
Time frame: 1 and 3 months postoperatively
Wavefront aberrometry using iTrace Tracey aberrometer (Internal and total higher order and lower order aberrations)(microns)
Aberrometry will be performed using iTrace machine (Tracy Technologies, USA) at all follow up visits
Time frame: 1 and 3 months postoperatively
Quality of life outcomes assessment by the Catquest 9SF questionnaire
Patients will be requested to fill a questionnaire at all follow up visits
Time frame: 1 and 3 months postoperatively
Glare and halos questionnaire on 1-4 Likert scale
(1= no glare and halos, 2= infrequent; 3 = frequent and 4 = continuous)
Time frame: 1 and 3 months postoperatively
Plan to share: No
Started Oct 2019 (actual). Primary completion is estimated for May 2020, 7 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brighton and Sussex University Hospitals NHS Trust